KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 139 filers reported holding KRYSTAL BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,675,472 | +5.7% | 117,892 | +7.0% | 1.26% | -12.2% |
| Q2 2023 | $12,936,541 | +89.7% | 110,192 | +29.4% | 1.44% | +103.7% |
| Q1 2023 | $6,819,431 | -54.3% | 85,179 | -54.7% | 0.71% | -67.0% |
| Q4 2022 | $14,910,551 | +3.2% | 188,217 | -9.2% | 2.14% | +8.9% |
| Q3 2022 | $14,451,000 | +2.6% | 207,332 | -3.3% | 1.96% | -10.6% |
| Q2 2022 | $14,083,000 | -26.8% | 214,482 | -25.9% | 2.20% | -11.6% |
| Q1 2022 | $19,252,000 | +20.5% | 289,337 | +26.7% | 2.48% | +55.2% |
| Q4 2021 | $15,979,000 | +143.8% | 228,437 | +82.0% | 1.60% | +56.7% |
| Q3 2021 | $6,554,000 | +42.7% | 125,529 | +85.9% | 1.02% | +44.6% |
| Q2 2021 | $4,592,000 | -64.3% | 67,529 | -59.5% | 0.71% | -69.5% |
| Q1 2021 | $12,854,000 | +1956.6% | 166,844 | +1500.7% | 2.32% | +2724.4% |
| Q4 2020 | $625,000 | – | 10,423 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |